Articles From: Another Strong Showing for Foreign Equity Funds in February, Morningstar Canada Data Show to Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus


2013/3/4
Another Strong Showing for Foreign Equity Funds in February, Morningstar Canada Data Show Canada NewsWire TORONTO , March 4, 2013 /CNW/ - February was yet another month of exceptional returns for foreign equity funds sold in Canada , while most balanced, fixed income and domestic equity fund categories also posted strong gains.
Sign-up for Another Strong Showing for Foreign Equity Funds in February, Morningstar Canada Data Show investment picks
2013/3/19
-- Technology Leaders to Demonstrate Performance of 100 Gbps Components for High-speed Optical Networks at OFC/NFOEC -- ANAHEIM, Calif.
Sign-up for Anritsu MP1800A BERT Part of High-speed Demonstrations of Mindspeed CDR Retimers investment picks
2013/4/4
MILAN --
Sign-up for Ansaldo STS Consortium Gets EUR120 Million Morocco Contract investment picks
2013/4/22
PITTSBURGH, April 22, 2013 (GLOBE NEWSWIRE) -- ANSYS, Inc. (Nasdaq:ANSS) today announced that 20-year Microsoft veteran Walid Abu-Hadba has joined the Company as chief product officer (CPO), effective immediately, reporting directly to Jim Cashman, president and CEO.
Sign-up for ANSYS Appoints Walid Abu-Hadba as Chief Product Officer investment picks
2013/4/18
PITTSBURGH, April 18, 2013 (GLOBE NEWSWIRE) -- ANSYS, Inc. (Nasdaq:ANSS) , announced today that James E.
Sign-up for ANSYS CEO to Present at Upcoming Investor Conferences investment picks
2013/5/2
Management Updates FY 2013 Guidance Highlights GAAP revenue of $197.7 million and non-GAAP revenue of $199.5 million GAAP diluted earnings per share of $0.54 and non-GAAP diluted earnings per share of $0.71 Operating cash flows of $95.4 million, a 14% increase over Q1 2012 GAAP operating profit margin of 35.2% and non-GAAP operating profit margin of 48.2% PITTSBURGH, May 2, 2013 (GLOBE NEWSWIRE) -- ANSYS, Inc. (Nasdaq:ANSS) , today announced growth in both revenue and diluted earnings per share for the first quarter of 2013.
Sign-up for ANSYS Delivers Record Revenue and Earnings for the First Quarter 2013 investment picks
2013/2/7
ANSYS® HFSS™ for ECAD with Cadence wins modeling and simulation tools category PITTSBURGH , Feb.
Sign-up for ANSYS Takes Home DesignCon Award For Second Year In A Row investment picks
2013/4/12
PITTSBURGH, April 12, 2013 (GLOBE NEWSWIRE) -- ANSYS, Inc. (Nasdaq:ANSS) announced today that the Company expects to release its first quarter 2013 earnings on Thursday, May 2, 2013.
Sign-up for ANSYS to Release First Quarter 2013 Earnings on May 2, 2013 investment picks
2013/4/3
PITTSBURGH and ZURICH, Switzerland, April 3, 2013 (GLOBE NEWSWIRE) -- ANSYS, Inc. (Nasdaq:ANSS) , a global innovator of simulation, and EVEN – Evolutionary Engineering AG  ("EVEN"), a leading provider of composite analysis and optimization technology relying on cloud computing, announced today that ANSYS has acquired EVEN, which will become ANSYS Switzerland, a wholly owned subsidiary of ANSYS, Inc. The terms of the transaction were not disclosed.
Sign-up for ANSYS, Inc. Announces Acquisition of EVEN - EVOLUTIONARY ENGINEERING AG investment picks
2013/2/25
PITTSBURGH, Feb.
Sign-up for ANSYS, Inc. Announces Annual Meeting of Stockholders and Sets Record Date investment picks
2013/2/21
PITTSBURGH, Feb.
Sign-up for ANSYS, Inc. Announces Increase to Authorized Share Repurchase Program investment picks
2013/2/28
Highlights Fourth quarter GAAP revenue of $220.7 million and non-GAAP revenue of $224.5 million Fiscal year 2012 GAAP revenue of $798.0 million and non-GAAP revenue of $807.7 million Fourth quarter GAAP diluted EPS of $0.59 and non-GAAP diluted EPS of $0.79 Fiscal year 2012 GAAP diluted EPS of $2.14 and non-GAAP diluted EPS of $2.91 Operating cash flows of $69.6 million for the fourth quarter and $298.4 million for fiscal year 2012 Fourth quarter and fiscal year 2012 GAAP operating profit margins of 37.0% and 36.9%, respectively, and non-GAAP operating profit margins of 49.3% and 50.1%, respectively Repurchase of 500,000 shares in the fourth quarter and 1.5 million shares in FY 2012 PITTSBURGH, Feb.
Sign-up for ANSYS, Inc. Reports Final Results for 2012: Record Revenue and Earnings for the Fourth Quarter and Fiscal Year 2012 investment picks
2013/3/11
PITTSBURGH, March 11, 2013 (GLOBE NEWSWIRE) -- ANSYS, Inc. (Nasdaq:ANSS) will be webcasting the ANSYS 2013 Investor Day being held at the Pittsburgh Renaissance Hotel on March 14, 2013.
Sign-up for ANSYS, Inc. to Webcast 2013 Investor Day investment picks
2013/2/27
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the New Drug Application (NDA) for OTREXUP™, a potential new product for the subcutaneous delivery of methotrexate (MTX) using Medi-Jet™ technology, has been accepted by the U.S. Food and Drug Administration (FDA) indicating that the application is sufficiently complete to permit a substantive review.
Sign-up for Antares Pharma Announces FDA Acceptance of New Drug Application for OTREXUP™ investment picks
2013/4/3
Antares Pharma, Inc. (NASDAQ: ATRS) today announced the first shipment of commercial-ready VIBEX™ auto-injector devices to Teva at the end of the first quarter 2013.
Sign-up for Antares Pharma Announces First Shipment of Commercial VIBEX™ Auto-Injector Devices to Teva investment picks
2013/4/5
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has received a Notice of Allowance from the U.S. Patent Trade Office (USPTO) on a patent application for the VIBEX™ QuickShot (QS) device, the latest advancement in its proprietary line of VIBEX™ auto-injector systems.
Sign-up for Antares Pharma Announces Notice of Allowance for New Patent on VIBEX™ QuickShot Device investment picks
2013/4/16
Antares Pharma, Inc. (NASDAQ: ATRS) today announced the issuance of U.S. Patent number 8,419,686 which relates to the device-injection site contacting interface.
Sign-up for Antares Pharma Announces the Issuance of a New Patent on VIBEX™ Device Platform investment picks
2013/5/8
Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the first quarter ended March 31, 2013.
Sign-up for Antares Pharma Reports First Quarter 2013 Operating and Financial Results investment picks
2013/3/13
Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the fourth quarter and full year ended December 31, 2012.
Sign-up for Antares Pharma Reports Fourth Quarter and Full Year 2012 Operating and Financial Results investment picks
2013/5/1
Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its first quarter 2013 operating and financial results before the market opens on Wednesday, May 8, 2013, and host a conference call shortly thereafter at 8:30 a.m. ET (Eastern Time) to discuss the results.
Sign-up for Antares Pharma to Host First Quarter 2013 Operating and Financial Results Conference Call investment picks
2013/3/6
Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its fourth quarter 2012 financial results before the market opens on Wednesday, March 13, 2013, and host a conference call shortly thereafter at 8:30 a.m. ET (Eastern Time) to discuss the results.
Sign-up for Antares Pharma to Host Fourth Quarter 2012 Call investment picks
2013/2/20
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K.
Sign-up for Antares Pharma to Participate in the 2013 RBC Capital Markets’ Healthcare Conference investment picks
2013/5/9
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K.
Sign-up for Antares Pharma to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference investment picks
2013/2/26
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K.
Sign-up for Antares Pharma to Present at the Cowen and Company 33rd Annual Healthcare Conference investment picks
2013/2/19
http://media.marketwire.com/attachments/201302/TN-57277_image986924.jpg AJ Schlake-Betz, Managing Director, Anthem Worldwide (Canada) http://media.marketwire.com/attachments/201105/26166_23917_Anthem.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=986924&ProfileId=051205&sourceType=1 TORONTO --
Sign-up for Anthem Worldwide Appoints AJ Schlake-Betz Managing Director of Anthem's Canadian Headquarters investment picks
2013/2/5
http://media.marketwire.com/attachments/201210/52598_anthem_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=981081&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Anthem Worldwide Consumer Insights Study Reveals "Older and Wiser" Trumps "Youthfulness" as Trend in 2013 investment picks
2013/1/29
http://media.marketwire.com/attachments/201210/52598_anthem_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=978954&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Anthem Worldwide Consumer Insights Study Reveals What Women Really Want From Health and Wellness investment picks
2013/2/7
http://media.marketwire.com/attachments/201210/52598_anthem_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=982475&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Anthem Worldwide Consumer Insights Study Reveals, "Consumer Engaged, Shopper Informed," a Ruling Trend in 2013 investment picks
2013/2/12
http://media.marketwire.com/attachments/201210/52598_anthem_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=984213&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Anthem Worldwide Consumer Insights Study Reveals, "Creating It Myself," a Driving Trend in 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Another Strong Showing for Foreign Equity Funds in February, Morningstar Canada Data Show to Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity